Tags

Type your tag names separated by a space and hit enter

Management of patients with ovarian cancer in the COVID-19 era.
J Surg Oncol. 2020 Aug; 122(2):122-123.JS

Abstract

At the beginning of 2020, coronavirus disease 2019 (COVID-19) spreads worldwide. Patients with ovarian cancer should be considered at high-risk of developing severe morbidity related to COVID-19. Most of them are diagnosed in advanced stages of disease, and they are fragile. Here, we evaluated the major impact of COVID-19 on patients with ovarian cancer, discussing the effect of the outbreak on medical and surgical treatment.

Links

PMC Free PDF

Authors+Show Affiliations

Bogani G
Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Casarin J
Obstetrics and Gynecology Department of the University of Insubria, Varese, Italy.
Pinelli C
Obstetrics and Gynecology Department of the University of Insubria, Varese, Italy.
Di Donato V
Department of Maternal and Child Health and Urological Sciences, "Sapienza" University of Rome, Rome, Italy.
Bosio S
Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. Department of Obstetrics and Gynecology, Ospedale San Paolo, University of Milan, Milan, Italy.
Ruisi S
Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. Department of Obstetrics and Gynecology, Ospedale San Paolo, University of Milan, Milan, Italy.
Brusadelli C
Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. Obstetrics and Gynecology Department of the University of Insubria, Varese, Italy.
Guerrisi R
Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. Obstetrics and Gynecology Department of the University of Insubria, Varese, Italy.
Sarpietro G
Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. Department of General Surgery and Medical Surgical Specialties, Gynecological Clinic University of Catania, Catania, Italy.
Ditto A
Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Ghezzi F
Obstetrics and Gynecology Department of the University of Insubria, Varese, Italy.
Raspagliesi F
Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

MeSH

BetacoronavirusCOVID-19Coronavirus InfectionsFemaleGynecologic Surgical ProceduresHumansInfection ControlInfectious Disease Transmission, Patient-to-ProfessionalLaparoscopyOvarian NeoplasmsPandemicsPneumonia, ViralSARS-CoV-2Surgical Oncology

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32476155

Citation

Bogani, Giorgio, et al. "Management of Patients With Ovarian Cancer in the COVID-19 Era." Journal of Surgical Oncology, vol. 122, no. 2, 2020, pp. 122-123.
Bogani G, Casarin J, Pinelli C, et al. Management of patients with ovarian cancer in the COVID-19 era. J Surg Oncol. 2020;122(2):122-123.
Bogani, G., Casarin, J., Pinelli, C., Di Donato, V., Bosio, S., Ruisi, S., Brusadelli, C., Guerrisi, R., Sarpietro, G., Ditto, A., Ghezzi, F., & Raspagliesi, F. (2020). Management of patients with ovarian cancer in the COVID-19 era. Journal of Surgical Oncology, 122(2), 122-123. https://doi.org/10.1002/jso.26057
Bogani G, et al. Management of Patients With Ovarian Cancer in the COVID-19 Era. J Surg Oncol. 2020;122(2):122-123. PubMed PMID: 32476155.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Management of patients with ovarian cancer in the COVID-19 era. AU - Bogani,Giorgio, AU - Casarin,Jvan, AU - Pinelli,Ciro, AU - Di Donato,Violante, AU - Bosio,Sara, AU - Ruisi,Simona, AU - Brusadelli,Claudia, AU - Guerrisi,Rocco, AU - Sarpietro,Giuseppe, AU - Ditto,Antonino, AU - Ghezzi,Fabio, AU - Raspagliesi,Francesco, Y1 - 2020/05/31/ PY - 2020/05/16/received PY - 2020/05/20/revised PY - 2020/05/22/accepted PY - 2020/6/2/pubmed PY - 2020/8/12/medline PY - 2020/6/2/entrez KW - COVID-19 KW - SARS-CoV KW - chemotherapy KW - ovarian cancer KW - surgery SP - 122 EP - 123 JF - Journal of surgical oncology JO - J Surg Oncol VL - 122 IS - 2 N2 - At the beginning of 2020, coronavirus disease 2019 (COVID-19) spreads worldwide. Patients with ovarian cancer should be considered at high-risk of developing severe morbidity related to COVID-19. Most of them are diagnosed in advanced stages of disease, and they are fragile. Here, we evaluated the major impact of COVID-19 on patients with ovarian cancer, discussing the effect of the outbreak on medical and surgical treatment. SN - 1096-9098 UR - https://www.unboundmedicine.com/medline/citation/32476155/Management_of_patients_with_ovarian_cancer_in_the_COVID_19_era_ DB - PRIME DP - Unbound Medicine ER -